HI
EDIT icon

Hoey Investments’s Editas Medicine EDIT Stock Holding History

Hoey Investments’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-250
Closed -$3K – 315
2022
Q3 		$3K Hold
250
– – ﹤0.01% 279
2022
Q2 		$3K Hold
250
– – ﹤0.01% 241
2022
Q1 		$5K Hold
250
– – ﹤0.01% 198
2021
Q4 		$7K Hold
250
– – ﹤0.01% 189
2021
Q3 		$10K Buy
+250
New +$13.7K ﹤0.01% 169

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Hoey Investments's EDIT Position: Q4 2022 in Review

Hoey Investments sold out of Editas Medicine (EDIT) in Q4 2022, closing a stake of 250 shares — an estimated $3K sold.

Hoey Investments first reported a position in EDIT in Q3 2021 and held it in 5 quarters. The position peaked at $10K in Q3 2021. 250 funds tracked by Wall St. Rank hold EDIT as of Q4 2022.

  • Hoey Investments reported no remaining Editas Medicine position as of Q4 2022 after selling out during the quarter.
  • Hoey Investments sold 250 Editas Medicine shares in Q4 2022, an estimated $3K.
  • Hoey Investments first reported a position in Editas Medicine in Q3 2021 and held it in 5 quarters.
  • Hoey Investments's Editas Medicine position peaked at $10K in Q3 2021.
  • 250 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2022.

Based on Hoey Investments's 13F filing for Q4 2022, filed 14 Feb 2023.